MedRhythms
Portland · Biotechnology, Information Technology · 26 employees
MedRhythms is a digital therapeutics company that uses sensors, music and software to build evidence-based neurologic interventions to measure and improve walking. The Company’s product pipeline consists of multiple clinical programs for neurologic conditions, the most advanced are in chronic stroke, multiple sclerosis, and Parkinson’s disease. MedRhythms was founded out of Spaulding Rehabilitatio
Funding history
- Series seed — $3.3M — Mar 2026
- Series seed — $2.9M — Apr 2025
- Funding Round — $19.8M — Jan 2024
- Funding Round — $19.0M — Dec 2023
- Funding Round — $5.8M — Feb 2023
Recent signals
- Mar 02, 2026: Raised $3.3M in Series seed
- Jul 07, 2025: MedRhythms Appoints Larry Jasinski as Chief Executive Officer
- Apr 03, 2025: Raised $2.9M in Series seed
- Feb 04, 2025: MedRhythms Hires Joel Behnke as Chief Commercial Officer
- Jan 16, 2025: Launched MedRhythms, Inc. Launches InTandem® Rehabilitation System for Chronic Stroke Gait Impairment, Receiving Medicare Payment Determination.
- Jan 09, 2024: Raised $19.8M
- Dec 12, 2023: Raised $19.0M
- Feb 22, 2023: Raised $5.8M
See plans & pricing → Track MedRhythms’s funding, hiring, and signals — with verified contacts — on Fundz.